Non-Narcotic Analgesics Market Drivers, Trends, and Forecast by 2031

MARKET INTRODUCTION

Non-narcotic analgesics are medications that are used to control pain and inflammation. Non-narcotic is a drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. Some types of these medications can be given during surgery to reduce post-surgical pain and lessen the need for narcotics.

MARKET DYNAMICS

The non-narcotic analgesics market is expected to grow due to increasing number of diseases. Moreover, increase in research and development activities is propelling the market growth in the forecast period.

MARKET SCOPE

The "Non-Narcotic Analgesics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of non-narcotic analgesics market with detailed market segmentation by of product, and application. The non-narcotic analgesics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in non-narcotic analgesics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The non-narcotic analgesics market is segmented on the basis of type and application. Based on type, the market is segmented as non-steroid antiinflammatory drug and others. On the basis of application, the market is categorized as hospital, medical center and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the non-narcotic analgesics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-narcotic analgesics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting non-narcotic analgesics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-narcotic analgesics market in these regions.

MARKET PLAYERS

The report covers key developments in the non-narcotic analgesics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from non-narcotic analgesics market are anticipated to have lucrative growth opportunities in the future with the rising demand for non-narcotic analgesics in the global market. Below mentioned is the list of few companies engaged in the non-narcotic analgesics market.

The report also includes the profiles of key players in non-narcotic analgesics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Akron, Inc.
  
•   Allergan plc
  
•   BioDelivery Sciences International, Inc.
  
•   Endo Pharmaceuticals
  
•   GlaxoSmithKline PLC
  
•   Novartis AG
  
•   Pfizer
  
•   Reckitt Benckiser
  
•   Sanofi S.A.
  
•   Teva Pharmaceuticals
  
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Non-Narcotic Analgesics Report Scope